Literature DB >> 207775

Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

R E Paque, C J Gauntt, T J Nealon, M D Trousdale.   

Abstract

Hypertonic KCl extracts prepared from heart tissues of adolescent CD-1 mice inoculated with coxsackievirus B3 (CVB3) were tested for antigenicity in evaluating cell-mediated sensitivity to CVB3 virus utilizing the agarose droplet cell-migration-inhibition assay. Immune mouse peritoneal exudate cells (IMPEC) from mice immunized against CVB3 virus and Freund's complete adjuvant were specifically inhibited in the cell-migration-inhibition assay with graded doses of KCl-extracted antigen and purified protein derivative (PPD). Unimmunized for "normal" mouse peritoneal exudate cells (NMPEC) were not inhibited in the presence of the CVB3 KCl extracts. KCl heart extracts from mice inoculated with a cardiotropic strain of antigenically distinct mengovirus failed to inhibit CVB3 IMPEC, and noncardiac KCl extracts of liver and spleen from CVB3-inoculated mice also failed to inhibit cellular migration of CVB3 IMPEC. Reciprocal specificity experiments utilizing KCl-extracted antigens from mice infected with antigenically distinct cardiotropic mengovirus failed to inhibit cellular migration of IMPEC from mice immunized against the mengovirus. Serum-blocking power experiments indicate the antigenic KCl extracts failed to bind virus-neutralizing antibodies, indicating absence of detectable quantities of virion antigens. The results indicate that inoculation of mice with CVB3 virus results in the appearance of a new antigen(s) in cardiac tissue reacting with CVB3-IMPEC, but not with mengovirus IMPEC.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207775

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells.

Authors:  Y Matoba; B Sherry; B N Fields; T W Smith
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

3.  Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.

Authors:  M Estrin; C Smith; S Huber
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

Review 4.  Role of cytotoxic T cells in experimental myocarditis.

Authors:  N Van Houten; S A Huber
Journal:  Springer Semin Immunopathol       Date:  1989

Review 5.  Anti-viral and anti-myocyte antibodies in experimental myocarditis.

Authors:  M Herzum; B Maisch
Journal:  Springer Semin Immunopathol       Date:  1989

6.  Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.

Authors:  M D Trousdale; R E Paque; T Nealon; C J Gauntt
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 7.  Diagnosing and treating active myocarditis.

Authors:  J B O'Connell; J W Mason
Journal:  West J Med       Date:  1989-04

8.  Rickettsial perimyocarditis--a follow-up study.

Authors:  B Maisch
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

9.  Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Authors:  C J Gauntt; R E Paque; M D Trousdale; R J Gudvangen; D T Barr; G J Lipotich; T J Nealon; P S Duffey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.

Authors:  B Maisch; R Trostel-Soeder; E Stechemesser; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.